LightSNiP assay is a good strategy for Pharmacogenetics Test
Saved in:
Main Authors: | Stefania eCheli (Author), Filippo ePietrantonio (Author), Emilio eClementi (Author), Felicia Stefania Falvella (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2015-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping
by: Montrasio C, et al.
Published: (2023) -
Response to: “Challenges in DPYD Test Implementation in Patients Treated with Fluoropyirimidines, is DPYD Genotype Arriving on Time?” [Response to Letter]
by: Montrasio C, et al.
Published: (2024) -
Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges
by: Stefania Cheli, et al.
Published: (2023) -
Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure
by: Silvia Corti, et al.
Published: (2019) -
GH dysfunction in Engrailed-2 knockout mice, a model for autism spectrum disorders
by: Giovanni eProvenzano, et al.
Published: (2014)